|
|
|
Volumn 54, Issue 1, 1999, Pages 17-21
|
|
Cholesterol-related cardiovascular risk: From a continuum to the definition of normal values, intervention threshold and therapeutic goals;Le risque cardio-vasculaire lie a l'hypercholesterolemie: d'Un continuum a la notion de normalite, de seuil d'intervention et d'objectif therapeutique
a
|
|
Author keywords
Cardiovascular risk; Hypercholesterolaemia; Pharmaco economics; Target population; Therapeutic goals
|
|
Indexed keywords
COLESTYRAMINE;
GEMFIBROZIL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PRAVASTATIN;
SIMVASTATIN;
CARDIOVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
DIAGNOSTIC VALUE;
EVIDENCE BASED MEDICINE;
HIGH RISK POPULATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYPERCHOLESTEROLEMIA;
REFERENCE VALUE;
RESOURCE ALLOCATION;
REVIEW;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL;
DRUG COSTS;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYPERCHOLESTEROLEMIA;
PATIENT SELECTION;
REFERENCE VALUES;
RISK FACTORS;
|
|
EID: 0032912549
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (21)
|
|
References (16)
|
